-+ 0.00%
-+ 0.00%
-+ 0.00%

Aquestive Therapeutics Q4 Adj. EPS $(0.15) Misses $(0.13) Estimate, Sales $13.015M Miss $13.284M Estimate

Benzinga·03/04/2026 21:02:29
Listen to the news
Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 12.78 percent. This is a 21.05 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $13.015 million which missed the analyst consensus estimate of $13.284 million by 2.03 percent. This is a 9.67 percent increase over sales of $11.867 million the same period last year.